Hangzhou Diagens Biotechnology Co., Ltd.
Hangzhou Diagens Biotechnology Co., Ltd. (HKSE: 2526) is trading at HK$335.40, about ₹4,104 at today's HKD/INR rate, as of 28 Sep 2026, 4:08 AM ET, down 6.83% today. Indian residents can buy Hangzhou Diagens Biotechnology from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$326.80
Today's high
HK$390.00
52 week low
HK$178.00
52 week high
HK$765.50
2526 opened at HK$360.00, closed previously at HK$360.00, and has traded between HK$178.00 and HK$765.50 over the past 52 weeks.
About
Hangzhou Diagens Biotechnology Co., Ltd., a medical devices company, develops medical imaging products and services. It operates through Medical Imaging Software and Medical Devices, Technology Licensing, Analysis and Consulting Services, and Others segments. The company's products portfolio include AI AutoVision, a chromosome karyotype assisted diagnosis and analysis system that provides intelligent karyotyping analysis with applications across genetics and hematologic oncology; MetaSight automatic cell microscopic image scanning system, which enables automated scanning, positioning, image acquisition, and output of chromosome or cell samples for a range of cytogenetics applications, including genetics health, radiation health, and hemato-oncology; and KayoFlow automatic cell harvester for pre-analytical processing of various sample types, including peripheral blood, amniotic fluid, and bone marrow. It also offers KayoFlow integrated slide preparation and staining system for pre-analytical slide preparation and staining of chromosome samples; KayoFlow workflow integration systems; and laboratory reagents and consumables. In addition, the company provides integrated storage, computation, training, and inference localized solutions; and iMed MaaS medical imaging AI platform, a cloud-based service platform. Hangzhou Diagens Biotechnology Co., Ltd. was founded in 2016 and is headquartered in Hangzhou, China.
Key statistics
Avg. volume
77.86K
Market cap
HK$29.81B
P/E Ratio
—
Price-to-sales ratio
—
Enterprise value
—
Free cash flow yield
—
Debt-to-equity ratio
—
Return on equity
—
ROIC
—
Beta
0.81
Dividend yield
—
Last dividend
HK$0.00
Financial overview
Revenue
—
Earnings per share
—
Free cash flow
—
Net profit margin
—
Gross margin
—
EBITDA
—
Revenue growth
—
How to buy Hangzhou Diagens Biotechnology from India
Indian residents can buy Hangzhou Diagens Biotechnology shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Hangzhou Diagens Biotechnology and place an order
Find Hangzhou Diagens Biotechnology by name or by its ticker, 2526, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Hangzhou Diagens Biotechnology trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Hangzhou Diagens Biotechnology position in HKD and INR. Hangzhou Diagens Biotechnology pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Hangzhou Diagens Biotechnology from India
Trading and taxes when buying Hangzhou Diagens Biotechnology from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneHangzhou Diagens Biotechnology does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Hangzhou Diagens Biotechnology stock?
Yes. Hangzhou Diagens Biotechnology (2526) has been listed on the Hong Kong Stock Exchange since 2026, in the Medical - Devices industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Hangzhou Diagens Biotechnology share cost in rupees?
One Hangzhou Diagens Biotechnology share is HK$335.40 — about ₹4,104 at an HKD/INR rate of 12.24 on 27 Sep 2026. Both the Hangzhou Diagens Biotechnology price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Hangzhou Diagens Biotechnology from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Hangzhou Diagens Biotechnology?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Hangzhou Diagens Biotechnology shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Hangzhou Diagens Biotechnology price. Paasa issues a capital-gains statement for your return.
Does Hangzhou Diagens Biotechnology pay a dividend?
No. Hangzhou Diagens Biotechnology does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Hangzhou Diagens Biotechnology from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Hangzhou Diagens Biotechnology a Hong Kong SAR China company, and does that change how it is taxed?
Hangzhou Diagens Biotechnology trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Hangzhou Diagens Biotechnology trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Hangzhou Diagens Biotechnology shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Hangzhou Diagens Biotechnology holding, its cost and its closing value.
How do I sell Hangzhou Diagens Biotechnology and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.